| SC 13G | 2014-09-02 | Cormorant Asset Management, LLC | Cellectar Biosciences, Inc. | 1,060,000 | - | EDGAR |
| SC 13G | 2014-08-20 | SABBY MANAGEMENT, LLC | Cellectar Biosciences, Inc. | 474,545 | 6.5% | EDGAR |
| SC 13G | 2013-03-14 | Flynn James E | NOVELOS THERAPEUTICS, INC. | 6,163,595 | 10.0% | EDGAR |
| SC 13G/A | 2011-04-12 | LONGVIEW FUND LP | NOVELOS THERAPEUTICS, INC. | 34,414,145 | 7.6% | EDGAR |
| SC 13G/A | 2011-02-14 | Xmark Opportunity Partners, LLC | NOVELOS THERAPEUTICS, INC. | 1,627,794 | 0.0% | EDGAR |
| SC 13G | 2011-02-14 | LONGVIEW FUND LP | NOVELOS THERAPEUTICS, INC. | 44,413,360 | 8.6% | EDGAR |
| SC 13G | 2010-12-10 | Xmark Opportunity Partners, LLC | NOVELOS THERAPEUTICS, INC. | 34,311,724 | 7.0% | EDGAR |